Brief Information of the Cell Line and Protein
Cell Line ID: CL000011 , CHO
Synonyms
Chinese Hamster Ovary
CHO-ori
Category Spontaneously immortalized cell line
Organism
Cricetulus griseus (Chinese hamster)
Cellosaurus ID
CVCL_0213
Protein ID: PT06233 , Relaxin-3 receptor 2
Gene Name RXFP4
Organism Homo sapiens, Human
Protein Classification Membrane receptor
Uniprot ID Q8TDU9
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000011  Protein ID: PT06233
 
Compound ID Compound Name Compound Formula
CP0959505
3,3'-((4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,37S,40S,43R,48R,51S,54S,57S,60S,63S,66S,69S,72S,75S,81R)-37-((1H-indol-3-yl)methyl)-43-amino-48-((6S,9S)-1-amino-6-((S)-1-carboxy-2-(1H-indol-3-yl)ethylcarbamoyl)-9-(hydroxymethyl)-1-imino-8,11,14-trioxo-2,7,10,13-tetraazapentadecan-15-ylcarbamoyl)-25,40-bis(4-aminobutyl)-54,69-dibenzyl-16,57,66-tri-sec-butyl-4-carboxy-81-((3S,9S,12S,15S)-1-((S)-1-((S)-2-((S)-2-((S)-2-((S)-1-carboxy-2-(1H-indol-3-yl)ethylamino)-5-guanidinopentanamido)propanamido)propanoyl)pyrrolidin-2-yl)-12-(3-guanidinopropyl)-3-(4-hydroxybenzyl)-15-isobutyl-9-isopropyl-1,4,7,10,13-pentaoxo-2,5,8,11,14-pentaazahexadecanamido)-63,75-bis(3-guanidinopropyl)-51-((R)-1-hydroxyethyl)-10,13,22,28-tetrakis(hydroxymethyl)-7-isobutyl-60-isopropyl-31-methyl-6,9,12,15,18,21,24,27,30,33,36,39,42,50,53,56,59,62,65,68,71,74,77,80-tetracosaoxo-1,2,45,46-tetrathia-5,8,11,14,17,20,23,26,29,32,35,38,41,49,52,55,58,61,64,67,70,73,76,79-tetracosaazacyclodooctacontane-19,72-diyl)dipropanoic acid
   Show/Hide
C207H316N60O55S4
 1
1
EC50 = 6.918 nM
   TI
   LI
   LO
   TS
CP0962324
(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,37S,40S,43R,48R,51S,54S,57S,60S,63S,66S,69S,72S,75S,81R)-81-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-acetamido-3-amino-3-oxopropoxy]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-methylpentanoyl]amino]-43-amino-25,40-bis(4-aminobutyl)-54,69-dibenzyl-16,57,66-tris[(2S)-butan-2-yl]-48-[[2-[[2-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]carbamoyl]-63,75-bis(3-carbamimidamidopropyl)-19,72-bis(2-carboxyethyl)-51-[(1R)-1-hydroxyethyl]-10,13,22,28-tetrakis(hydroxymethyl)-37-(1H-indol-3-ylmethyl)-31-methyl-7-(2-methylpropyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,50,53,56,59,62,65,68,71,74,77,80-tetracosaoxo-60-propan-2-yl-1,2,45,46-tetrathia-5,8,11,14,17,20,23,26,29,32,35,38,41,49,52,55,58,61,64,67,70,73,76,79-tetracosazacyclodooctacontane-4-carboxylic acid
   Show/Hide
C212H324N62O57S4
 1
1
EC50 = 7.079 nM
   TI
   LI
   LO
   TS
CP0958721
(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,37S,40S,43R,48R,51S,54S,57S,60S,63S,66S,69S,72S,75S,81R)-43-amino-25,40-bis(4-aminobutyl)-81-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-methylpentanoyl]amino]-54,69-dibenzyl-16,57,66-tris[(2S)-butan-2-yl]-48-[[2-[[2-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]carbamoyl]-63,75-bis(3-carbamimidamidopropyl)-19,72-bis(2-carboxyethyl)-51-[(1R)-1-hydroxyethyl]-10,13,22,28-tetrakis(hydroxymethyl)-37-(1H-indol-3-ylmethyl)-31-methyl-7-(2-methylpropyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,50,53,56,59,62,65,68,71,74,77,80-tetracosaoxo-60-propan-2-yl-1,2,45,46-tetrathia-5,8,11,14,17,20,23,26,29,32,35,38,41,49,52,55,58,61,64,67,70,73,76,79-tetracosazacyclodooctacontane-4-carboxylic acid
   Show/Hide
C207H317N61O54S4
 1
1
EC50 = 14.45 nM
   TI
   LI
   LO
   TS
CP0959506
(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,37S,40S,43R,48R,51S,54S,57S,60S,63S,66S,69S,72S,75S,81R)-43-amino-25,40-bis(4-aminobutyl)-54,69-dibenzyl-16,57,66-tris[(2S)-butan-2-yl]-81-[[(2S)-2-[[(2S)-5-carbamimidamido-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-5-carbamimidamido-2-[[(2S)-1-carbamoyloxy-3-(1H-indol-3-yl)propan-2-yl]amino]pentanoyl]amino]propanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]pentanoyl]amino]-4-methylpentanoyl]amino]-48-[[2-[[2-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]carbamoyl]-63,75-bis(3-carbamimidamidopropyl)-19,72-bis(2-carboxyethyl)-51-[(1R)-1-hydroxyethyl]-10,13,22,28-tetrakis(hydroxymethyl)-37-(1H-indol-3-ylmethyl)-31-methyl-7-(2-methylpropyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,50,53,56,59,62,65,68,71,74,77,80-tetracosaoxo-60-propan-2-yl-1,2,45,46-tetrathia-5,8,11,14,17,20,23,26,29,32,35,38,41,49,52,55,58,61,64,67,70,73,76,79-tetracosazacyclodooctacontane-4-carboxylic acid
   Show/Hide
C208H319N61O55S4
 1
1
EC50 = 19.5 nM
   TI
   LI
   LO
   TS
CP0955896
(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,37S,40S,43R,48R,51S,54S,57S,60S,63S,66S,69S,72S,75S,81R)-43-amino-25,40-bis(4-aminobutyl)-54,69-dibenzyl-16,57,66-tris[(2S)-butan-2-yl]-81-[[(2S)-2-[[(2S)-5-carbamimidamido-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-5-carbamimidamido-2-[[(2S)-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]amino]pentanoyl]amino]propanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]pentanoyl]amino]-4-methylpentanoyl]amino]-48-[[2-[[2-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]carbamoyl]-63,75-bis(3-carbamimidamidopropyl)-19,72-bis(2-carboxyethyl)-51-[(1R)-1-hydroxyethyl]-10,13,22,28-tetrakis(hydroxymethyl)-37-(1H-indol-3-ylmethyl)-31-methyl-7-(2-methylpropyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,50,53,56,59,62,65,68,71,74,77,80-tetracosaoxo-60-propan-2-yl-1,2,45,46-tetrathia-5,8,11,14,17,20,23,26,29,32,35,38,41,49,52,55,58,61,64,67,70,73,76,79-tetracosazacyclodooctacontane-4-carboxylic acid
   Show/Hide
C207H318N60O54S4
 1
1
EC50 = 281.84 nM
   TI
   LI
   LO
   TS